Article
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.
Transplantation and cellular therapy - 1 Jul 2023
Narayan Rupa, Niroula Abhishek, Wang Tao, Kuxhausen Michelle, He Meilun, Meyer Everett, Chen Yi-Bin, Bhatt Vijaya Raj, Beitinjaneh Amer, Nishihori Taiga, Sharma Akshay, Brown Valerie I, Kamoun Malek, Diaz Miguel A, Abid Muhammad Bilal, Askar Medhat, Kanakry Christopher G, Gragert Loren, Bolon Yung-Tsi, Marsh Steven G E, Gadalla Shahinaz M, Paczesny Sophie, Spellman Stephen, Lee Stephanie J
Abstract excerpt
Mutation-bearing peptide ligands from mutated nucleophosmin-1 (NPM1) protein have been empirically found to be presented by HLA class I in acute myeloid leukemia (AML). We hypothesized that HLA genotype may impact allogeneic hematopoietic stem cell transplantation (allo-HCT) outcomes in NPM1-mutated AML owing to differences in antigen presentation. We evaluated the effect of the variable of predicted strong...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
